Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Medtronic

Benzinga's Top Ratings Upgrades, Downgrades For May 27, 2022

Upgrades

Benzinga

Medtronic, DaVita To Jointly Form Kidney Health-Focused Company

Medtronic plc (NYSE:MDT) and DaVita Inc (NYSE:DVA) intend to form a new, independent kidney care-focused medical device company (NewCo). NewCo will focus on developing a broad suite of novel kidney care products and solutions, including future home-based products. Medtronic and DaVita will co-own the NewCo, each with equal equity stakes and led by an…

Benzinga

Why Medtronic Shares Are Plunging Today?

Medtronic Plc's (NYSE:MDT) Q4 FY22 sales of $8.09 billion decreased 1% Y/Y on a reported basis but increased 1% organically, missing the consensus of $8.42 billion. The company has forecasted Q4 organic revenue growth of approximately 5.5%. Q4 adjusted EPS of $1.52 increased 2%, missing the analyst consensus of $1.56. Medtronic's heart device…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Medtronic: Q4 Earnings Insights

Medtronic (NYSE:MDT) reported its Q4 earnings results on Thursday, May 26, 2022 at 06:45 AM. Here's what investors need to know about the announcement.

Benzinga

Medtronic's Earnings: A Preview

Medtronic (NYSE:MDT) is set to give its latest quarterly earnings report on Thursday, 2022-05-26. Here's what investors need to know before the announcement. Analysts estimate that Medtronic will report an earnings per share (EPS) of $1.56.

Benzinga

4 Analysts Have This to Say About Medtronic

Within the last quarter, Medtronic (NYSE:MDT) has observed the following analyst ratings:

Benzinga

2 Wide-Moat Stocks to Add to Your Portfolio Right Now

The major stock market indexes surged yesterday after the Fed Reserve raised benchmark interest rates by half a percentage point. However, the stock market is expected to remain under pressure at least in the near term on continuing macroeconomic and geopolitical concerns. So, we think it could be wise to…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Acutus Medical Stock Soars On Debt Refinancing, Divestiture Of Left-Heart Access Portfolio

Acutus Medical Inc (NASDAQ:AFIB) shares are skyrocketing on a commitment letter from Deerfield Management Company to refinance its existing debt with a new longer-term credit facility. The Company has also agreed to sell its left-heart access portfolio to Medtronic plc (NYSE:MDT). The combination of these two transactions, taken together with the Company’s recently completed restructuring,…

Benzinga

Medtronic vs. Edwards Lifesciences: Which Medical Device Stock is a Better Buy?

Growing demand from an aging population to track their diseases and increased focus on critical surgical procedures with lesser COVID-19 pressures on hospitals make the medical devices industry’s prospects bright. Moreover, the integration of emerging technologies and continued innovations should drive the industry’s growth. Therefore, prominent players in this space,…

StockNews.com

Medtronic Recalls Harmony Delivery Catheter Due Risk Of Breaking While Procedure

Medtronic Plc (NYSE:MDT) is recalling the Harmony Delivery Catheter, part of the Transcatheter Pulmonary Valve (TPV), due to the possibility that the bond holding the capsule at the end of the delivery catheter may break during a procedure. Harmony TPV System is used to treat a leaky native or surgically repaired right…

Benzinga

Medtronic's Portfolio Management Unlikely To Be A 'Magic Bullet,' Says Needham

Needham published a report that pointed to previous comments from Medtronic plc's (NYSE: MDT) management that indicate the potential for changes in the coming year, with a spinoff of a large business considered an option.

Benzinga

3 Wide-Moat Stocks That Look Cheap: Biogen, Medtronic, and Bristol-Myers Squibb

: Major stock indices appear heading for weekly gains with the Fed’s first interest rate hike digested easily by investors. However, the market is expected to remain under pressure in the near term. So, because wide-moat companies generally do well in these market conditions, we think cheap wide-moat stocks Bristol-Myers…

StockNews.com

Medtronic's US Trial Of GI Genius Endoscopy Module Reduces Missed Colorectal Polyps By 50%

Medtronic plc (NYSE:MDT) announced final findings from a study that confirmed the effectiveness of the GI Genius intelligent endoscopy module. GI Genius uses AI to aid in detecting colorectal polyps during colonoscopy, potentially helping to prevent colorectal cancer (CRC). The study published in Gastroenterology found that the use of GI Genius in conjunction with…

Benzinga

FDA Approves Medtronic's Recharge-Free Sacral Nerve Stimulation Therapy For Bladder, Bowel Control

The FDA has approved Medtronic plc's (NYSE:

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Medtronic's Q3 Profit In Line With Expectation Despite COVID-19 Impact On Procedure Volume

Medtronic Plc's (NYSE: MDT) Q3 FY22 sales of $7.76

Benzinga

Recap: Medtronic Q3 Earnings

Medtronic (NYSE:MDT) reported its Q3 earnings results on Tuesday, February 22, 2022 at 06:45 AM. Here's what investors need to know about the announcement.

Benzinga

Medtronic Scores Expanded FDA Nod For Cardiac Cryoablation Catheters In Pediatric Patients With Heart Rhythm Condition

The

Benzinga

Expert Ratings For Medtronic

Within the last quarter, Medtronic (NYSE:MDT) has observed the following analyst ratings:

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What 20 Analyst Ratings Have To Say About Medtronic

Medtronic (NYSE:MDT) has observed the following analyst ratings within the last quarter:

Benzinga

Where Medtronic Stands With Analysts

Medtronic (NYSE:MDT) has observed the following analyst ratings within the last quarter:

Benzinga

Medtronic Issues Voluntary Recall For TurboHawk Plus Directional Atherectomy System

Medtronic Plc (NYSE: MDT) has initiated a voluntary recall to customers related to the risk associated with tip damage caused by guidewire prolapse in its 6 French (6Fr) TurboHawk Plus Directional Atherectomy System.

Benzinga

Analyst Ratings For Medtronic

Analysts have provided the following ratings for Medtronic (NYSE:MDT) within the last quarter:

Benzinga

10 Biggest Price Target Changes For Tuesday

Needham cut Medtronic plc (NYSE: MDT) price target from $131 to $128. Medtronic shares fell 0.7% to $103.44 in pre-market trading.

Benzinga

Medtronic Recalls HawkOne Atherectomy System Due To Tip Damage Risk

Medtronic Inc (NYSE: MDT) is recalling HawkOne Directional Atherectomy System due to the risk of the guidewire within the

Tribune News Service

FDA: Medtronic slow to update, recall defective insulin pumps for diabetes patients

While the U.S. Food and Drug Administration acknowledges Medtronic is actively working on fixing issues within its diabetes business, especially in regard to some of its insulin pumps, it says the steps took too long and are not enough.

1 … 3 4 5 6

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

1,409 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.